Clinical Trial

Cutaneous Silent Period-Based Comparison of DRG-PRF and TFESI in Lumbar Radicular Pain

Study acronym: CSP-LRP
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 5, 2025 (before its estimated August 25, 2025 completion). Its status may not reflect the trial's current state.
Summary
This prospective clinical study compares the effects of two interventional treatments, dorsal root ganglion pulsed radiofrequency (DRG-PRF) and transforaminal epidural steroid injection (TFESI), on patients with lumbar radicular pain (LRP). A third group of healthy individuals is included as a control group to provide baseline cutaneous silent period (CSP) values. The CSP is a neurophysiological marker of spinal inhibition. The study aims to evaluate whether these treatments affect pain levels, functional disability, and CSP parameters over time. Participants with LRP will receive either DRG-PRF or TFESI, while healthy controls will undergo CSP testing only. The findings may provide insight into the effects of these interventions on segmental nociceptive processing and inform treatment strategies for neuropathic low back pain.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-25.
Trial Details
NCT Number NCT07097532
Lead Sponsor ahmet başarı
Conditions Lumbar Radicular Pain, Spinal, Inhibition
Enrollment 54 participants
Start Date 2025-07-08
Primary Completion 2025-08-25 (estimated)
Study Completion 2025-08-25 (estimated)
Updated on ClinicalTrials.gov 2025-08-05